Compare FNB & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNB | TXG |
|---|---|---|
| Founded | 1864 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.0B |
| IPO Year | 2002 | 2019 |
| Metric | FNB | TXG |
|---|---|---|
| Price | $19.11 | $58.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 15 |
| Target Price | $19.70 | ★ $20.25 |
| AVG Volume (30 Days) | ★ 6.1M | 3.0M |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | 22.83 | ★ 76.97 |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $14.12 | N/A |
| Revenue Next Year | $8.35 | $7.33 |
| P/E Ratio | $23.63 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $14.46 | $11.17 |
| 52 Week High | $19.59 | $59.87 |
| Indicator | FNB | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 76.85 |
| Support Level | $18.40 | $17.54 |
| Resistance Level | $19.09 | N/A |
| Average True Range (ATR) | 0.33 | 3.55 |
| MACD | -0.03 | 0.78 |
| Stochastic Oscillator | 54.79 | 98.23 |
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).